This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
March 23, 2015
Oncopeptides Receives EMA and FDA Orphan Drug Designation for Melflufen in the Treatment of Multiple Myeloma
March 20, 2015
BOOKBUILDING SUCCESSFULLY COMPLETED – OFFER SHARES PRICED AT NOK 32 PER SHARE RAISING NOK 500 MILLION IN GROSS PROCEEDS
March 18, 2015
Cortendo AB Names John H. Johnson as Chairman and Appoints Richard Kollender as Director
March 17, 2015
VAXIN CEO TO PRESENT AT FUTURE LEADERS IN THE BIOTECH INDUSTRY CONFERENCE
March 17, 2015
NORDIC NANOVECTOR – INCREASE IN OFFERING SIZE AND NARROWING OF THE INDICATIVE PRICE RANGE
March 12, 2015
NORDIC NANOVECTOR – STATUS ON BOOKBUILDING
March 11, 2015
NORDIC NANOVECTOR – LAUNCH OF INITIAL PUBLIC OFFERING
March 09, 2015
NEXSTIM PLC PUBLISHES 2014 ANNUAL REPORT
March 09, 2015
NORDIC NANOVECTOR – CHANGE IN THE BOARD OF DIRECTORS
March 06, 2015
AEROCRINE AB RECEIVES FDA CLEARANCE FOR NIOX VERO® BLUETOOTH® WIRELESS ENHANCEMENT